Press Releases

05.12.16
OpGen Announces Pricing of $10 Million Private Placement
05.10.16
OpGen, Inc. Announces Timing for First Quarter Financial Results and Conference Call
05.04.16
OpGen and District of Columbia Hospital Association Complete First Citywide Quantification of Multidrug-Resistant Organism (MDRO) Prevalence in Washington, D.C.-based Healthcare Facilities
05.02.16
OpGen Appoints Harry J. D'Andrea to Board of Directors
04.11.16
New Study Data Show OpGen’s QuickFISH® Blood Culture Pathogen ID Tests to be Rapid and Cost-Effective, with Utility to Inform Antimicrobial Stewardship Decisions
03.30.16
OpGen Announces 2015 Fourth Quarter and Full Year Financial Results
03.21.16
OpGen Announces New Members to its Clinical Advisory Board
03.16.16
OpGen, Inc. Announces Timing for 2015 Fourth Quarter and Year End Financial Results and Conference Call
02.03.16
OpGen to Present at Source Capital Group’s 2016 Disruptive Growth & Healthcare Conference
01.13.16
OpGen, Inc., to Present at Noble Financial Capital Markets’ 12th Annual Investor Conference